HAYWARD, Calif., January 08, 2026--(BUSINESS WIRE)--RefleXion Medical, an external-beam theranostic oncology company, today announced the U.S. Food and Drug Administration has cleared its next ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results